Lv5
1190 积分 2023-12-24 加入
A Novel CSN5 Inhibitor Drives Tumor-Intrinsic PD-L1 Degradation and Exerts Direct Antitumor Efficacy in Triple-Negative Breast Cancer
3个月前
已完结
Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy
3个月前
已完结
Advances in the Study of Hyperprogression of Different Tumors Treated with PD-1/PD-L1 Antibody and the Mechanisms of Its Occurrence
5个月前
已完结
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
5个月前
已完结
Paradigm shift in oncology: targeting the immune system rather than cancer cells
5个月前
已完结
Discovery of the first dual PD-L1/JAK inhibitor with enhanced in vivo antitumor immunity
6个月前
已关闭
Therapeutic inhibition of USP7 promotes antitumor immune responses
7个月前
已完结
Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies
7个月前
已完结
New KV7.2/3 Channel Activators Exhibit Superior Toxicity and Metabolic Profiles to Flupirtine and Demonstrate Promising In Vivo Analgesic Effects
9个月前
已完结
Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials
10个月前
已完结
皖公网安备34019202002308
